AFA
RMD icon

Abacus FCF Advisors’s ResMed RMD Stock Holding History

Abacus FCF Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,362
Closed -$2.83M – 134
2024
Q4 		$2.83M Buy
12,362
+5,103
+70% +$1.23M 0.37% 81
2024
Q3 		$1.77M Buy
+7,259
New +$1.62M 0.41% 94
2021
Q4 		– Sell
-5,330
Closed -$1.49M – 135
2021
Q3 		$1.49M Buy
5,330
+5
+0.1% +$1.37K 0.72% 50
2021
Q2 		$1.3M Sell
5,325
-385
-7% -$80.9K 0.66% 56
2021
Q1 		$1.09M Buy
+5,710
New +$1.14M 0.55% 77
2016
Q2 		– Sell
-31,657
Closed -$1.83M – 114
2016
Q1 		$1.83M Sell
31,657
-9,108
-22% -$516K 1.05% 35
2015
Q4 		$2.19M Buy
+40,765
New +$2.3M 1% 47

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Abacus FCF Advisors's RMD Position: Q1 2025 in Review

Abacus FCF Advisors sold out of ResMed (RMD) in Q1 2025, closing a stake of 12,362 shares — an estimated $2.83M sold.

Abacus FCF Advisors first reported a position in RMD in Q4 2015 and held it in 7 quarters. The position peaked at $2.83M in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Abacus FCF Advisors reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Abacus FCF Advisors sold 12,362 ResMed shares in Q1 2025, an estimated $2.83M.
  • Abacus FCF Advisors first reported a position in ResMed in Q4 2015 and held it in 7 quarters.
  • Abacus FCF Advisors's ResMed position peaked at $2.83M in Q4 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Abacus FCF Advisors's 13F filing for Q1 2025, filed 15 Apr 2025.